UniProtKB/Swiss-Prot Q969S9: Variant p.Asp576Glu

Ribosome-releasing factor 2, mitochondrial
Gene: GFM2
Feedback?

Variant information Variant position:

576 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Glutamate (E) at position 576 (D576E, p.Asp576Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and acidic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In COXPD39; uncertain significance; may affect splicing. Any additional useful information about the variant.

Sequence information Variant position:

576 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

779 The length of the canonical sequence.
Location on the sequence:

YLGPLQVAYRETILNSVRAT D TLDRTLGDKRHLVTVEVEAR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YLGPLQVAYRETILNSVRATDTLDRTLGDKR--HLVTVEVE------------------AR

Mouse                         YLGPLQVAYRETILNSVRATDTLDRVLGDKR--HLVSAELE

Rat                           YLGPLQVAYRETILNSVRATDTLDRVLGDKR--HFARAELE

Bovine                        YLGPLQVAYREAILNSIRATDTLDRTLGDKR--HLVTVELE

Zebrafish                     HLGPLQVAYRETILQSATAKDLLDRILGEKR--HVVSVELT

Drosophila                    DLGPLQIAYKETIEAPALTTLSVEKEIAGSK--QSVSITLE

Baker's yeast                 EFGQLMVSYKETI-NSETNIETYESDDGYRF--SLSLLPNS

Fission yeast                 SLGKVQVGYRETLIDVSFNSVTLSTENKENLIINVYLIPIS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 779	Ribosome-releasing factor 2, mitochondrial
Alternative sequence	514 – 779	Missing. In isoform 5.
Alternative sequence	532 – 709	Missing. In isoform 4.

Literature citations
Exome sequencing can improve diagnosis and alter patient management.
Dixon-Salazar T.J.; Silhavy J.L.; Udpa N.; Schroth J.; Bielas S.; Schaffer A.E.; Olvera J.; Bafna V.; Zaki M.S.; Abdel-Salam G.H.; Mansour L.A.; Selim L.; Abdel-Hadi S.; Marzouki N.; Ben-Omran T.; Al-Saana N.A.; Sonmez F.M.; Celep F.; Azam M.; Hill K.J.; Collazo A.; Fenstermaker A.G.; Novarino G.; Akizu N.; Garimella K.V.; Sougnez C.; Russ C.; Gabriel S.B.; Gleeson J.G.;
Sci. Transl. Med. 4:138RA78-138RA78(2012)
Cited for: VARIANT COXPD39 GLU-576;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.